What are the effectiveness and safety of low-dose Cyclosporin as monotherapy or combined with corticosteroids used as induction and long-term therapy in idiopathic membranous nephropathy with nephrotic syndrome?
¿Qué efecto y seguridad tiene la ciclosporina a dosis bajas, en monoterapia o asociada a esteroides, utilizada como inducción y como tratamiento a largo plazo de la nefropatía membranosa idiopática con síndrome nefrótico?
X. Fulladosa
Read
3133
Timeswas read the article
537
Total PDF
2596
Total HTML
Article information
ISSN: 20132514Original language: English
The statistics are updated each day
| Year/Month | Html | Total | |
|---|---|---|---|
| 2025 6 | 39 | 0 | 39 |
| 2025 5 | 45 | 0 | 45 |
| 2025 4 | 49 | 0 | 49 |
| 2025 3 | 58 | 0 | 58 |
| 2025 2 | 53 | 0 | 53 |
| 2025 1 | 30 | 0 | 30 |
| 2024 12 | 31 | 0 | 31 |
| 2024 11 | 25 | 0 | 25 |
| 2024 10 | 25 | 0 | 25 |
| 2024 9 | 46 | 0 | 46 |
| 2024 8 | 48 | 0 | 48 |
| 2024 7 | 24 | 0 | 24 |
| 2024 6 | 43 | 0 | 43 |
| 2024 5 | 37 | 0 | 37 |
| 2024 4 | 27 | 0 | 27 |
| 2024 3 | 22 | 5 | 27 |
| 2024 2 | 27 | 10 | 37 |
| 2024 1 | 27 | 7 | 34 |
| 2023 12 | 17 | 8 | 25 |
| 2023 11 | 24 | 7 | 31 |
| 2023 10 | 27 | 12 | 39 |
| 2023 9 | 20 | 7 | 27 |
| 2023 8 | 23 | 5 | 28 |
| 2023 7 | 23 | 8 | 31 |
| 2023 6 | 30 | 9 | 39 |
| 2023 5 | 28 | 9 | 37 |
| 2023 4 | 14 | 2 | 16 |
| 2023 3 | 22 | 0 | 22 |
| 2023 2 | 14 | 8 | 22 |
| 2023 1 | 17 | 5 | 22 |
| 2022 12 | 23 | 1 | 24 |
| 2022 11 | 22 | 7 | 29 |
| 2022 10 | 19 | 1 | 20 |
| 2022 9 | 24 | 4 | 28 |
| 2022 8 | 25 | 9 | 34 |
| 2022 7 | 19 | 0 | 19 |
| 2022 6 | 19 | 9 | 28 |
| 2022 5 | 14 | 6 | 20 |
| 2022 4 | 20 | 3 | 23 |
| 2022 3 | 19 | 8 | 27 |
| 2022 2 | 28 | 4 | 32 |
| 2022 1 | 12 | 0 | 12 |
| 2021 12 | 15 | 5 | 20 |
| 2021 11 | 24 | 1 | 25 |
| 2021 10 | 10 | 10 | 20 |
| 2021 9 | 14 | 5 | 19 |
| 2021 8 | 19 | 3 | 22 |
| 2021 7 | 21 | 15 | 36 |
| 2021 6 | 12 | 35 | 47 |
| 2021 5 | 11 | 3 | 14 |
| 2021 4 | 18 | 25 | 43 |
| 2021 3 | 9 | 2 | 11 |
| 2021 2 | 16 | 3 | 19 |
| 2021 1 | 10 | 10 | 20 |
| 2020 12 | 8 | 0 | 8 |
| 2020 11 | 16 | 6 | 22 |
| 2020 10 | 7 | 4 | 11 |
| 2020 9 | 2 | 2 | 4 |
| 2020 8 | 20 | 7 | 27 |
| 2020 7 | 11 | 4 | 15 |
| 2020 6 | 6 | 4 | 10 |
| 2020 5 | 16 | 6 | 22 |
| 2020 4 | 16 | 6 | 22 |
| 2020 3 | 13 | 8 | 21 |
| 2020 2 | 18 | 8 | 26 |
| 2020 1 | 26 | 10 | 36 |
| 2019 12 | 9 | 7 | 16 |
| 2019 11 | 15 | 12 | 27 |
| 2019 10 | 2 | 1 | 3 |
| 2019 9 | 11 | 3 | 14 |
| 2019 8 | 8 | 2 | 10 |
| 2019 7 | 7 | 7 | 14 |
| 2019 6 | 9 | 0 | 9 |
| 2019 5 | 6 | 1 | 7 |
| 2019 4 | 8 | 5 | 13 |
| 2019 3 | 11 | 0 | 11 |
| 2019 2 | 4 | 4 | 8 |
| 2019 1 | 4 | 2 | 6 |
| 2018 12 | 27 | 10 | 37 |
| 2018 11 | 26 | 7 | 33 |
| 2018 10 | 29 | 18 | 47 |
| 2018 9 | 13 | 5 | 18 |
| 2018 8 | 10 | 4 | 14 |
| 2018 7 | 10 | 13 | 23 |
| 2018 6 | 7 | 8 | 15 |
| 2018 5 | 13 | 11 | 24 |
| 2018 4 | 11 | 5 | 16 |
| 2018 3 | 6 | 6 | 12 |
| 2018 2 | 8 | 6 | 14 |
| 2018 1 | 12 | 4 | 16 |
| 2017 12 | 12 | 7 | 19 |
| 2017 11 | 14 | 3 | 17 |
| 2017 10 | 9 | 10 | 19 |
| 2017 9 | 11 | 3 | 14 |
| 2017 8 | 9 | 6 | 15 |
| 2017 7 | 5 | 4 | 9 |
| 2017 6 | 10 | 4 | 14 |
| 2017 5 | 13 | 3 | 16 |
| 2017 4 | 3 | 1 | 4 |
| 2017 3 | 8 | 1 | 9 |
| 2017 2 | 11 | 2 | 13 |
| 2017 1 | 5 | 1 | 6 |
| 2016 12 | 15 | 4 | 19 |
| 2016 11 | 18 | 3 | 21 |
| 2016 10 | 23 | 6 | 29 |
| 2016 9 | 51 | 2 | 53 |
| 2016 8 | 73 | 0 | 73 |
| 2016 7 | 85 | 0 | 85 |
| 2016 6 | 55 | 0 | 55 |
| 2016 5 | 48 | 0 | 48 |
| 2016 4 | 38 | 0 | 38 |
| 2016 3 | 22 | 0 | 22 |
| 2016 2 | 25 | 0 | 25 |
| 2016 1 | 26 | 0 | 26 |
| 2015 12 | 59 | 0 | 59 |
| 2015 11 | 25 | 0 | 25 |
| 2015 10 | 29 | 0 | 29 |
| 2015 9 | 14 | 0 | 14 |
| 2015 8 | 24 | 0 | 24 |
| 2015 7 | 40 | 0 | 40 |
| 2015 6 | 8 | 0 | 8 |
| 2015 5 | 45 | 0 | 45 |
Show all
